A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
Abstract Objective Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug‐resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate aspects of pharmacological treatment of Norwegian patients with Dra...
Main Authors: | Katrine Heger, Caroline Lund, Margrete Larsen Burns, Marit Bjørnvold, Erik Sætre, Svein I. Johannessen, Cecilie Johannessen Landmark |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12413 |
Similar Items
-
Phenotypes of Dravet Syndrome
by: Rebecca Garcia-Sosa, et al.
Published: (2016-08-01) -
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
by: Manuela Contin, et al.
Published: (2021-03-01) -
Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012-08-01) -
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
by: Cameron S. Metcalf, et al.
Published: (2019-09-01) -
Dravet Syndrome—The Polish Family’s Perspective Study
by: Justyna Paprocka, et al.
Published: (2021-04-01)